EHealth Research Development from 2010 to 2026

M5V Stock  EUR 1.30  0.05  3.70%   
EHealth's Research Development is increasing over the last several years with slightly volatile swings. Research Development is predicted to flatten to about 51.9 M. During the period from 2010 to 2026 eHealth Research Development regressed destribution of quarterly values had coefficient of variationof  43.68 and r-value of  0.78. View All Fundamentals
 
Research Development  
First Reported
2010-12-31
Previous Quarter
96.4 M
Current Value
51.9 M
Quarterly Volatility
23.4 M
 
Credit Downgrade
 
Yuan Drop
 
Covid
 
Interest Hikes
Check EHealth financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among EHealth's main balance sheet or income statement drivers, such as Interest Expense of 13.5 M, Selling General Administrative of 313.9 M or Total Revenue of 420 M, as well as many indicators such as . EHealth financial statements analysis is a perfect complement when working with EHealth Valuation or Volatility modules.
  
This module can also supplement various EHealth Technical models . Check out the analysis of EHealth Correlation against competitors.
For more detail on how to invest in EHealth Stock please use our How to Invest in EHealth guide.
The Research Development trend for eHealth offers valuable insights into the company's financial trajectory and strategic direction. By examining multi-year patterns, investors can identify whether EHealth is strengthening or weakening its position, and how this metric correlates with broader market conditions and industry benchmarks.

Latest EHealth's Research Development Growth Pattern

Below is the plot of the Research Development of eHealth over the last few years. It is EHealth's Research Development historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in EHealth's overall financial position and show how it may be relating to other accounts over time.
Research Development10 Years Trend
Slightly volatile
   Research Development   
       Timeline  

EHealth Research Development Regression Statistics

Arithmetic Mean53,612,892
Geometric Mean49,303,411
Coefficient Of Variation43.68
Mean Deviation20,597,723
Median36,351,000
Standard Deviation23,417,290
Sample Variance548.4T
Range64.4M
R-Value0.78
Mean Square Error228.3T
R-Squared0.61
Significance0.0002
Slope3,621,025
Total Sum of Squares8773.9T

EHealth Research Development History

202651.9 M
202596.4 M
202183.8 M
202065.2 M
201947.1 M
201832 M
201732.9 M

About EHealth Financial Statements

EHealth stakeholders use historical fundamental indicators, such as EHealth's Research Development, to determine how well the company is positioned to perform in the future. Although EHealth investors may analyze each financial statement separately, they are all interrelated. For example, changes in EHealth's assets and liabilities are reflected in the revenues and expenses on EHealth's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in eHealth. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Research Development96.4 M51.9 M

Currently Active Assets on Macroaxis

When determining whether eHealth offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of EHealth's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Ehealth Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Ehealth Stock:
Check out the analysis of EHealth Correlation against competitors.
For more detail on how to invest in EHealth Stock please use our How to Invest in EHealth guide.
You can also try the Money Managers module to screen money managers from public funds and ETFs managed around the world.
Understanding that EHealth's value differs from its trading price is crucial, as each reflects different aspects of the company. Evaluating whether EHealth represents a sound investment requires analyzing earnings trends, revenue growth, technical signals, industry dynamics, and expert forecasts. In contrast, EHealth's trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.